Why You Should Invest In Growth Greats GlaxoSmithKline plc, easyJet plc And Britvic Plc

Royston Wild explains why earnings are primed to explode over at GlaxoSmithKline plc (LON: GSK), easyJet plc (LON: EZJ) and Britvic Plc (LON: BVIC).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am looking at three of the FTSE’s hottest growth stocks.

GlaxoSmithKline

I believe pharmaceutical giant GlaxoSmithKline (LSE: GSK) should deliver resplendent returns thanks to surging healthcare demand in emerging and developed markets alike.

The company was famously dragged over the coals in China for bribing doctors and hospitals to promote its products, and was eventually fined £297m for the scandal late in 2014. And the fallout of the crisis continues to smack product sales. But there is no doubt the Brentford company, like industry peers AstraZeneca and Hutchison MediTech, will reap the rewards from new markets like China thanks to surging wealth levels and rising populations.

The City expects the enduring problem of patent losses to push earnings 20% lower in 2015, although an 11% rebound is anticipated for next year. A subsequent P/E rating of 17.7 times for the current period may represent a slight premium to the benchmark of 15 times that indicates reasonable value, but I believe GlaxoSmithKline’s growing position in emerging regions, combined with a hot product pipeline, fully merits this marginally-heady reading.

easyJet

As economic conditions across the continent continue to recover, I believe that budget flyer easyJet (LSE: EZJ) should also enjoy solid earnings growth as traveller numbers head to the skies.

As well as benefitting from rising holidaymaker numbers, the Luton-based business is also seeing increasing demand from business commuters. And easyJet is expanding aggressively to latch onto these encouraging trends — last week announced plans to take on a further 1,140 cabin crew and pilots during the next year as it boosts the number of flights it operates and expands its routes.

With the airline also benefitting from low fuel costs, easyJet is expected to have clocked up yet another earnings increase in the 12 months to September 2015, this time by a chunky 19%. And a further 9% advance is chalked in by the number crunchers for fiscal 2016, resulting in a very attractive P/E ratio of 11.6 times. I reckon the flyer is a great bet for those seeking dependable bottom-line growth at low prices.

Britvic

Like GlaxoSmithKline, I believe that drinks darling Britvic (LSE: BVIC) should reap the rewards of rising product demand across the globe.

The Hertfordshire firm pulled off a coup earlier this month after securing the purchase of Brazilian drinks manufacturer ebba, giving it a chance to build its presence in one of the world’s largest soft drinks markets. Britvic is looking increasingly towards international markets to drive beverage volumes, a strategy the firm is hoping to exploit through further acquisitions and the roll-out of top-brand drinks like Robinsons and J2O in new geographies.

Britvic is anticipated to have enjoyed an 8% earnings advance in the year to September 2015, and an extra 9% rise is forecast for the current year. As a result the business sports a P/E ratio of just 13.9 times, a figure I consider very attractive given the firm’s ambitious growth strategy.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has recommended Britvic and GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Newspaper and direction sign with investment options
Investing Articles

When cheap markets meet favourable conditions, sentiment flips very quickly

London’s stock market is cheap — some sectors, even cheaper. Given a change in sentiment, the uprating could be substantial.

Read more »

Investing Articles

Empty Stocks and Shares ISA? I’d snap up these 3 stocks to start with!

Sumayya Mansoor explains how she would start to build wealth from scratch with an empty Stocks and Shares ISA and…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

7.7% yield and going cheap! Why is this unknown FTSE 250 stock flying?

It's no household name, but there's one FTSE 250 stock with a high dividend yield and booming profits that looks…

Read more »

Photo of a man going through financial problems
Investing Articles

I’d stop staring at the Nvidia share price and buy this FTSE 100 stock instead

This writer reckons there is a smarter way to invest in Nvidia today without taking on stock-specific risk. Here is…

Read more »

Young lady working from home office during coronavirus pandemic.
Top Stocks

5 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Young Asian man drinking coffee at home and looking at his phone
Dividend Shares

These 3 FTSE 250 stocks offer me the highest dividend yields, but should I buy?

Jon Smith considers FTSE 250 shares with a very high yield, but questions whether the income is going to be…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Is FTSE 100 takeover target DS Smith a great buy?

A mega-merger between FTSE 100 giants DS Smith and Mondi has the City abuzz. But is there any value in…

Read more »

Young Black man sat in front of laptop while wearing headphones
Investing Articles

The WPP share price dips as profits fall. Here’s why it could be a top dividend buy

I'm starting to think the WPP share price undervalues the stock, especially if the long-term dividend outlook comes good.

Read more »